LOXL2 and cancer: It was reported that overexpression of LOXL2 drove EMT via upregulating the expression of SNAIL (SNAI1/2), ZEB (ZEB1/2) via IRE1-XBP1 signaling pathway or FAK/SRC signaling pathway in cancer cells (39, 40).